BIOHAVEN LTD (BHVN) Stock Analyst Ratings
USA - New York Stock Exchange - NYSE:BHVN - VGG1110E1079 - Common Stock
13.76 USD
+0.89 (+6.92%)
13.56 USD
-0.2 (-1.45%)
ChartMill assigns a Buy % Consensus number of 80% to BHVN. The Buy consensus is the weighted average rating of the current analysts ratings.
- Analysts have set a mean price target forecast of 20.33. This target is 47.76% above the current price.
- BHVN was analyzed by 23 analysts. The buy percentage consensus is at 80. So analysts seem to be have mildly positive about BHVN.
- In the previous month the buy percentage consensus was at a similar level.
- BHVN was analyzed by 23 analysts, which is quite many. So the average rating should be quite meaningful.
Price Target & Forecast
| Date | Firm | Action | Rating |
|---|---|---|---|
| 2026-01-21 | RBC Capital | Upgrade | Sector Perform -> Outperform |
| 2026-01-06 | Morgan Stanley | Maintains | Overweight -> Overweight |
| 2025-12-26 | HC Wainwright & Co. | Reiterate | Neutral -> Neutral |
| 2025-12-03 | HC Wainwright & Co. | Downgrade | Buy -> Neutral |
| 2025-11-26 | UBS | Downgrade | Buy -> Neutral |
| 2025-11-20 | JP Morgan | Maintains | Overweight -> Overweight |
| 2025-11-18 | BTIG | Reiterate | Buy -> Buy |
| 2025-11-18 | Morgan Stanley | Maintains | Overweight -> Overweight |
| 2025-11-13 | Citigroup | Maintains | Buy -> Buy |
| 2025-11-06 | Bernstein | Downgrade | Outperform -> Market Perform |
| 2025-11-06 | BTIG | Maintains | Buy -> Buy |
| 2025-11-06 | RBC Capital | Maintains | Sector Perform -> Sector Perform |
| 2025-11-05 | TD Cowen | Maintains | Buy -> Buy |
| 2025-11-05 | William Blair | Downgrade | Outperform -> Market Perform |
| 2025-09-17 | Citigroup | Initiate | Buy |
| 2025-09-16 | UBS | Maintains | Buy -> Buy |
| 2025-09-03 | Raymond James | Initiate | Strong Buy |
| 2025-08-19 | BTIG | Maintains | Buy -> Buy |
| 2025-08-12 | Leerink Partners | Maintains | Outperform -> Outperform |
| 2025-08-12 | Baird | Maintains | Outperform -> Outperform |
| 2025-08-12 | B of A Securities | Maintains | Buy -> Buy |
| 2025-08-12 | Morgan Stanley | Maintains | Overweight -> Overweight |
| 2025-08-12 | HC Wainwright & Co. | Maintains | Buy -> Buy |
| 2025-06-18 | JP Morgan | Maintains | Overweight -> Overweight |
| 2025-05-19 | RBC Capital | Downgrade | Outperform -> Sector Perform |
| 2025-05-13 | RBC Capital | Maintains | Outperform -> Outperform |
| 2025-04-28 | Baird | Maintains | Outperform -> Outperform |
| 2025-03-07 | Morgan Stanley | Maintains | Overweight -> Overweight |
| 2025-03-05 | JP Morgan | Maintains | Overweight -> Overweight |
| 2025-03-04 | RBC Capital | Reiterate | Outperform -> Outperform |
BIOHAVEN LTD / BHVN FAQ
Can you provide the average price target for BIOHAVEN LTD stock?
23 analysts have analysed BHVN and the average price target is 20.33 USD. This implies a price increase of 47.76% is expected in the next year compared to the current price of 13.76.
How do analysts rate BIOHAVEN LTD (BHVN)?
The consensus rating for BIOHAVEN LTD (BHVN) is 80 / 100 . This indicates that analysts generally have a positive outlook on the stock.
Can you provide the analyst count for BIOHAVEN LTD stock?
The number of analysts covering BIOHAVEN LTD (BHVN) is 23.